C0000274692P
This role supports the development of next-generation T cell receptor (TCR)-engineered T cell therapies by preparing engineered TCR-T cells and testing their biological properties. The position reports to the Assistant Lead and works collaboratively with the broader team to deliver IND-ready candidates for the clinic. Responsibilities include supporting IND-enabling preclinical studies, generating engineered TCR-transduced T cells, and performing cell-based function assays.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for C0000274692P.
C0000274692P didn’t post a salary, so this is our estimate from similar listings.
56% below the average for this role
Research Scientist (Basic Life Research Scientist)
Oracle
Research Scientist (Basic Life Research Scientist)
Oracle
Research Scientist (Basic Life Research Scientist)
Oracle
(Senior) Principal Scientist, Cell Therapy
PharmaEssentia
T-Cell Engineering Scientist
Charterhouse
Senior Associate Scientist - Engineered Cell Therapy Discovery
Bristol Myers Squibb